Die Welt der medizinischen Blogs

FDA Approves a New Treatment Option for Those With Severe Asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and

weiterlesen »

Kommentarfunktion ist deaktiviert